Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 5/20 | 0.55 |
| ▸ | NOS3 | P29474 | 2/20 | 0.49 |
| ▸ | NOS2 | P35228 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29498359 | 1.00 | MAPK10 (0.55) | MAPK10NOS3NOS2MAOAHTR1A | |
| SCHEMBL29498358 | 1.00 | MAPK10 (0.55) | MAPK10NOS3NOS2MAOAHTR1A | |
| SCHEMBL163051 | 0.85 | MAPK10 (0.55) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL29384557 | 0.85 | MAPK10 (0.55) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL30965966 | 0.85 | NOS3 (0.47) | MAPK10NOS3NOS2MAOAHTR1A | |
| Hydrochloric Acid SCHEMBL27495714 | 0.84 | MAPK10 (0.54) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL6718892 | 0.83 | NOS3 (0.58) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL13805616 | 0.83 | NOS3 (0.49) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL21063722 | 0.83 | CA1 (0.52) | MAPK10NOS3NOS2MAOAALDH1A1 | |
| SCHEMBL28542282 | 0.83 | MAPK10 (0.50) | MAPK10NOS3NOS2MAOAHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113950477-B | Granulin precursor modulators and methods of use thereof | 阿库达医疗公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-114195713-B | Method for synthesizing dihydroisoquinoline by catalyzing selective dehydrogenation of tetrahydroisoquinoline | 广东众源药业有限公司 | 2023-11-17 | — | — | CN | disclosed |
| EP-3724188-B1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2023-06-07 | — | — | EP | disclosed |
| EP-3724188-B1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS | 2022-12-29 | — | — | US | disclosed |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS | 2022-12-29 | — | — | US | disclosed |
| EP-4048677-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2022-08-31 | — | — | EP | disclosed |
| US-20220251084-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | JANSSEN PHARMACEUTICA NV (BE) | 2022-08-11 | — | — | US | disclosed |
| CN-112500345-B | Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound | 西安石油大学 | 2022-06-21 | — | — | CN | disclosed |
| EP-3983401-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2020252222-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020252222-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2020-12-17 | — | — | WO | disclosed |
| EP-3724188-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2020-10-21 | — | — | EP | disclosed |
| WO-2019118528-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2019-06-20 | — | — | WO | disclosed |
| WO-2019118528-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2019-06-20 | — | — | WO | disclosed |
| US-7964292-B2 | Metal complex, light-emitting device, and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964292-B2 | Metal complex, light-emitting device, and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20070228940-A1 | METAL COMPLEX, LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
| US-20070228940-A1 | METAL COMPLEX, LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
| US-4321382-A | 2-Amino-11b-aryl-benzo[a]quinolizines | RICHARDSON-MERRELL INC. (US) | 1982-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251084-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | GRN, PRNP, PSEN2 | MAPK10 2055/4885NOS3 4353/4885NOS2 4393/4885 |
| US-20070228940-A1 | METAL COMPLEX, LIGHT-EMITTING DEVICE, AND DISPLAY APPARATUS | LAGE3, EMC2, INTS9 | MAPK10 2123/4885NOS3 2064/4885NOS2 1223/4885 |
| US-20220409593-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | GRN, PSEN1, PSEN2 | MAPK10 1664/4885NOS3 4047/4885NOS2 3871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.